Medicare Enrolled

Dr. Candise Love, RN

Oncology Registered Nurse · Port Huron, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1231 PINE GROVE AVE, Port Huron, MI 48060
8109825200
In practice since 2010 (15 years)
NPI: 1801102371 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Love from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Love? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Love

Dr. Candise Love is an oncology registered nurse in Port Huron, MI, with 15 years of NPI registration. Based on federal Medicare data, Dr. Love performed 237 Medicare services across 183 unique beneficiaries.

Between the years covered by Open Payments, Dr. Love received a total of $10,262 from 68 pharmaceutical and/or device companies across 449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in oncology registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Love is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 29% volume in MI $10,262 industry payments

Medicare Practice Summary

Medicare Utilization ↗
237
Medicare services
Top 29% in MI for oncology registered nurse
183
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
74 $53 $140
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
62 $33 $85
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
42 $114 $400
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
38 $80 $214
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
21 $87 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,262
Total received (2021-2024)
Avg $2,566/year across 4 years
Top 0% in MI for oncology registered nurse
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
449
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,563 (83.4%)
Other
Charitable contributions, space rental, and other categories
$1,320 (12.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$379 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,966
2023
$2,207
2022
$2,153
2021
$1,936

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,320
AstraZeneca Pharmaceuticals LP
$262
Merck Sharp & Dohme LLC
$219
ABBVIE INC.
$204
Incyte Corporation
$177
E.R. Squibb & Sons, L.L.C.
$148
Eisai Inc.
$135
Lilly USA, LLC
$131
Genentech USA, Inc.
$126
Ipsen Biopharmaceuticals, Inc
$109
Daiichi Sankyo Inc.
$98
BeiGene USA, Inc.
$98
Janssen Biotech, Inc.
$76
Mirati Therapeutics, Inc.
$76
Astellas Pharma US Inc
$72
SOBI, INC
$62
Celgene Corporation
$61
GlaxoSmithKline, LLC.
$58
Pharmacosmos Therapeutics Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$50
Agios Pharmaceuticals, Inc.
$42
Gilead Sciences, Inc.
$38
Janssen Scientific Affairs, LLC
$36
RECORDATI_RARE_DISEASES_INC.
$26
Karyopharm Therapeutics Inc.
$25
Kite Pharma, Inc.
$25
Acrotech Biopharma Inc.
$24
Stemline Therapeutics Inc.
$23
Myriad Genetic Laboratories, Inc.
$22
Sumitomo Pharma America, Inc.
$22
Apellis Pharmaceuticals, Inc.
$21
ImmunoGen, Inc.
$21
Tempus AI, Inc
$20
PFIZER INC.
$19
GENZYME CORPORATION
$19
ARRAY BIOPHARMA INC
$19
Deciphera Pharmaceuticals Inc.
$17
Spectrum Pharmaceuticals Inc.
$14
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$2,016
AstraZeneca Pharmaceuticals LP
$765
Janssen Biotech, Inc.
$543
Merck Sharp & Dohme LLC
$505
Incyte Corporation
$421
Eisai Inc.
$340
Lilly USA, LLC
$302
Takeda Pharmaceuticals U.S.A., Inc.
$297
ABBVIE INC.
$274
Genentech USA, Inc.
$247
Daiichi Sankyo Inc.
$238
Amgen Inc.
$235
Seagen Inc.
$224
Astellas Pharma US Inc
$200
GENZYME CORPORATION
$193
AbbVie Inc.
$172
AMAG Pharmaceuticals, Inc.
$172
Gilead Sciences, Inc.
$168
EMD Serono, Inc.
$165
ASD Specialty Healthcare, LLC
$164
E.R. Squibb & Sons, L.L.C.
$162
BeiGene USA, Inc.
$151
Celgene Corporation
$142
Ipsen Biopharmaceuticals, Inc
$142
Mirati Therapeutics, Inc.
$131
Merck Sharp & Dohme Corporation
$130
GlaxoSmithKline, LLC.
$104
SERVIER PHARMACEUTICALS LLC
$80
Deciphera Pharmaceuticals Inc.
$78
EAGLE PHARMACEUTICALS, INC.
$75
Karyopharm Therapeutics Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$67
Bayer Healthcare Pharmaceuticals Inc.
$65
Regeneron Healthcare Solutions, Inc.
$64
Sumitomo Pharma America, Inc.
$62
SOBI, INC
$62
PFIZER INC.
$58
Myriad Genetic Laboratories, Inc.
$55
Kite Pharma, Inc.
$55
Sobi, Inc
$54
Pharmacosmos Therapeutics Inc.
$54
Genmab U.S., Inc.
$50
MACROGENICS, INC.
$49
AVEO Pharmaceuticals, Inc.
$44
PharmaEssentia USA Corporation
$43
Agios Pharmaceuticals, Inc.
$42
Pharmacyclics LLC, an AbbVie Company
$42
Acrotech Biopharma LLC
$41
Janssen Scientific Affairs, LLC
$36
PUMA BIOTECHNOLOGY, INC.
$33
Dova Pharmaceuticals
$31
MorphoSys, US Inc.
$27
RECORDATI_RARE_DISEASES_INC.
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
Acrotech Biopharma Inc.
$24
TAIHO ONCOLOGY, INC.
$24
Stemline Therapeutics Inc.
$23
Rigel Pharmaceuticals, Inc.
$21
Apellis Pharmaceuticals, Inc.
$21
ImmunoGen, Inc.
$21
Tempus AI, Inc
$20
EISAI INC.
$20
ARRAY BIOPHARMA INC
$19
G1 Therapeutics, Inc.
$17
TerSera Therapeutics LLC
$17
Clovis Oncology, Inc.
$16
Spectrum Pharmaceuticals Inc.
$14
Aveo Pharmaceuticals, Inc.
$12
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · BALVERSA · BAVENCIO · BELEODAQ · BESREMI · BRUKINSA · Blincyto · CALQUENCE · COSELA · CREON · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ENHERTU · ERLEADA · Empaveli · Enhertu · Epkinly · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · HEMADY · HYQVIA · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PEMFEXY · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SYLVANT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · Vanflyta · Venclexta · XARELTO · XPOVIO · XTANDI · Xtandi · Yescarta · ZEJULA · Zoladex · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 0% for oncology registered nurse in MI.

Looking for an oncology registered nurse in Port Huron?
Compare oncology registered nurses in the Port Huron area by procedure volume, costs, and industry payment transparency.
Browse oncology registered nurses nearby

Geographic Context

Oncology registered nurses within 10 mi
1
Per 100K population
0.6
County median income
$69,349
Nearest hospital
LAKE HURON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Love is a mixed practice specialist, with above-average Medicare volume (top 29% in MI), with low-engagement industry engagement in the top 0% of MI peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Love experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Love performed 74 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Love receive payments from pharmaceutical companies?
Yes. Dr. Love received a total of $10,262 from 68 companies across 449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Love's costs compare to other oncology registered nurses in Port Huron?
Dr. Love's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Love) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →